MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Ataxia: Clinical features"

  • 2018 International Congress

    A clinical and pathological study of small fibers in Friedreich´s Ataxia

    E. Indelicato, W. Nachbauer, A. Eigentler, A. Fanciulli, J.P. Ndayisaba, W. Poewe, G. Wenning, J. Wanschitz, S. Boesch (Innsbruck, Austria)

    Objective: To investigate the small fibers pathology in Friedreich´s Ataxia (FRDA). Background: FRDA is an inherited movement disorder caused by homozygous GAA expansions in the…
  • 2018 International Congress

    Diagnostic tips from a case series of patients with Late Onset Tay Sachs disease

    G.M. Riboldi, K. Anstett, H. Lau (New York, NY, USA)

    Objective: To describe a population of eight patients with Late Onset Tay Sachs (LOTS) disease and offer tips to aid in diagnosing this rare condition.…
  • 2018 International Congress

    Case of Friedreich’s ataxia with extremely large repeat expansion without systemic disease

    K. Niotis, H. Ellsworth, J. Weaver, H. Sarva (New York, NY, USA)

    Objective: To describe a case of Friedreich’s ataxia with >1700 GAA repeats but no systemic manifestations despite long disease course. Background: Fredrich’s ataxia (FA) is…
  • 2018 International Congress

    Quantitative oculomotor assessment and non-motor biomarkers in late-onset GM2 gangliosidosis

    C. Stephen, D. Balkwill, P. James, K. Sassower, J. Schmahmann, R. Lewis, F. Eichler (Boston, MA, USA)

    Objective: To assess whether quantitative eye movement measures correlate with disease severity in late-onset GM2 gangliosidosis, and to perform exploratory assessments of novel cognitive/neuropsychiatric measures…
  • 2018 International Congress

    Slowly progressive anti-Ca/ARHGAP26 autoantibody-associated cerebellar ataxia over 27 years without immunosuppressive treatment

    E. Schegk, I. Beiser, A. Wicki, L. Achtnichts, M. Bertschi (Aarau, Switzerland)

    Objective: To discuss a slowly progressive case of anti-Ca/ARHGAP26 autoantibody-associated cerebellar ataxia. Background: Anti-Ca/ARHGAP26 autoantibody-associated cerebellar ataxia was first identified in 2010 (1). Since then,…
  • 2018 International Congress

    Non-motor symptoms in Spinocerebellar ataxia, multiple system atrophy and Idiopathic late-onset cerebellar ataxia

    YM. Park, MJ. Kim, SB. Koh (Seoul, Republic of Korea)

    Objective: Recent studies suggest that non-motor symptoms (NMS) including urinary disorders, erectile dysfunction in men, orthostatic hypotension, sleep disruption, constipation, depression and anxiety are common…
  • 2018 International Congress

    Treatment with docosahexaenoic acid in Spinocerebellar Ataxia 38

    D. Perani, L. Orsi, C. Costanzi, M. Ferrero, A. Zoppo, F. Tempia, D. Caruso, M. Grassi, A. Padovani, A. Brusco, B. Borroni (Brescia, Italy)

    Objective: To evaluate the safety and efficacy of docosahexaenoic acid supplementation in patients with spinocerebellar ataxia 38 (SCA 38), on clinical symptoms and changes of…
  • 2018 International Congress

    Acute Stroke in Middle Cerebellar Peduncle in a Patient with FXTAS

    A. Fraint, D. Hall, R. Dafer (Chicago, IL, USA)

    Objective: Report a case of Fragile X associated Tremor/Ataxia Syndrome (FXTAS) with acute middle cerebellar peduncle (MCP) infarction, and highlight the potential susceptibility of the…
  • 2018 International Congress

    Clinical characteristics of a family harbouring a novel CCDC88C mutation (SCA40)

    W. Nachbauer, E. Indelicato, A. Eigentler, S. Boesch (Innsbruck, Austria)

    Objective: We here report on clinical features and course of disease in a novel CCDC88C mutation causing spinocerebellar ataxia type 40 (SCA40). Background: SCA40 is…
  • 2018 International Congress

    Urinary symptoms and Urodynamic findings in patients with SCAs and DRPLA

    M. Jang, A. Kim, B. Jeon, H. Kim (Jeollabuk-do, Republic of Korea)

    Objective: To investigate the lower urinary tract symptoms (LUTS) and findings of the urodynamic study (UDS) in patients with spinocerebellar ataxia (SCA) and dentatorubral pallidoluysian…
  • « Previous Page
  • 1
  • …
  • 25
  • 26
  • 27
  • 28
  • 29
  • …
  • 34
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley